Biocompatibility of trillium biopassive surface-coated oxygenator versus uncoated oxygenator during cardiopulmonary bypass

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 15, Issue 5, 2001, Pages 545-550

  Stammers, Alfred H ^a  

^a UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

Author keywords

Biocompatibility; Cardiac surgery; Coatings; Complement; Platelet activation; Transfusion

Indexed keywords

ANTIPLASMIN; BETA THROMBOGLOBULIN; FIBRINOGEN; HEMOGLOBIN; HEPARIN; MYELOPEROXIDASE; PLASMIN; PROTHROMBIN;

ADULT; AGED; ARTICLE; BIOCOMPATIBILITY; BLEEDING; BLOOD CLOTTING TIME; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEMENT ACTIVATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; FEMALE; HEMATOCRIT; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MALE; OXYGENATOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE COUNT;

EID: 0034783119     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcan.2001.26525     Document Type: Article

References (21)

1. Coagulation tests predict bleeding after cardiopulmonary bypass
2. Coronary artery bypass grafting: The Society of Thoracic Surgeons national database experience
3. Loss of platelet fibrinogen receptors during clinical cardiopulmonary bypass
4. Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients
5. Hemostasis changes during cardiopulmonary bypass surgery
6. Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro
7. Effect of intentional hemodilution on platelet survival in secondary pulmonary hypertension
8. The contact activation system: Biochemistry and interactions of these surface-mediated defense reactions
9. Heparin-coated cardiopulmonary bypass circuits reduce blood cell trauma: Experiments in the pig
10. Platelet function in cardiopulmonary bypass and artificial organs
11. Biocompatibility of extracorporeal circulation
12. Heparin coating of an extracorporeal circuit partly improves hemostasis after cardiopulmonary bypass
13. Comparison of heparin coated extracorporeal circuit with a standard circuit in CABG surgery patients
14. Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: A prospective, randomized study
15. Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparinbonded cardiopulmonary bypass circuits
16. Contact, coagulation and platelet interaction with heparin treated equipment during heart surgery
17. Measurement of platelet adhesiveness: A simple in vitro technique demonstrating an abnormality in von Willebrand's disease
18. Influence of two blood conservation techniques (cardiotomy reservoir versus cell-saver) on biocompatibility of the heparin-coated cardiopulmonary bypass circuit during coronary revascularization surgery
19. Heparin-bonded circuits improve clinical outcomes in emergency coronary artery bypass grafting
20. Specific complement inhibition with heparin-coated extracorporeal circuits
21. Influence of Duraflo II heparin-treated extracorporeal circuits on the systemic inflammatory response in patients having coronary bypass